A shot in the foot of public health: Many health care workers won t get flu vaccine

By ACSH Staff — Oct 15, 2010
According to a Consumer Reports survey, 28 percent of health care workers do not plan to get this season s flu vaccine, which protects against H1N1 swine flu as well as the other likely flu virus strains, and is recommended by the CDC for everyone over the age of six months.

According to a Consumer Reports survey, 28 percent of health care workers do not plan to get this season s flu vaccine, which protects against H1N1 swine flu as well as the other likely flu virus strains, and is recommended by the CDC for everyone over the age of six months.

OOPS, FDA approved knee injury device in error

By ACSH Staff — Oct 15, 2010
The FDA admitted Thursday that it erroneously approved the knee injury device known as Menaflex in response to political pressure from four New Jersey federal legislators and a former FDA commissioner.

The FDA admitted Thursday that it erroneously approved the knee injury device known as Menaflex in response to political pressure from four New Jersey federal legislators and a former FDA commissioner.

FDA warns marketers of phony chelation treatments

By ACSH Staff — Oct 15, 2010
The FDA warned eight companies yesterday that their over-the-counter oral chelation products are unapproved drugs and any labels claiming that their products can treat various medical condition violate federal law. Several chelation products are advertised online as “all-natural” cures for ailments such as autism and Alzheimer’s disease.

The FDA warned eight companies yesterday that their over-the-counter oral chelation products are unapproved drugs and any labels claiming that their products can treat various medical condition violate federal law. Several chelation products are advertised online as “all-natural” cures for ailments such as autism and Alzheimer’s disease.

Canada declares BPA 'toxic'

By ACSH Staff — Oct 14, 2010
With the European Union regulators recently reaffirming the safety of bisphenol A, ACSH friend Jon Entine has a long (but breezy and well-written!) piece in the Huffington Post asking, “at what point will the science prevail?”

With the European Union regulators recently reaffirming the safety of bisphenol A, ACSH friend Jon Entine has a long (but breezy and well-written!) piece in the Huffington Post asking, “at what point will the science prevail?”

Vaccine-fearing parents responsible for measles outbreaks

By ACSH Staff — Oct 14, 2010
Parents philosophically opposed to the measles-mumps-rubella (MMR) vaccine are responsible for hundreds of sickened children in the last few years, government data show.

Parents philosophically opposed to the measles-mumps-rubella (MMR) vaccine are responsible for hundreds of sickened children in the last few years, government data show.

No evidence Tony Gwynn s rare cancer came from chewing tobacco

By ACSH Staff — Oct 14, 2010
Hall of Fame outfielder Tony Gwynn is being treated for salivary gland cancer — and he’s telling reporters he suspects it was caused by his career-long use of chewing tobacco.

Hall of Fame outfielder Tony Gwynn is being treated for salivary gland cancer — and he’s telling reporters he suspects it was caused by his career-long use of chewing tobacco.

Menu labeling has nominal effects

By ACSH Staff — Oct 13, 2010
The last time you were at McDonald’s, you may have thought twice about whether or not to indulge in a Big Mac after reading its total calorie content — or maybe you didn’t.

The last time you were at McDonald’s, you may have thought twice about whether or not to indulge in a Big Mac after reading its total calorie content — or maybe you didn’t.

Folic acid surprisingly doesn't decrease risk of heart disease

By ACSH Staff — Oct 13, 2010
High levels of the amino acid homocysteine have been associated with an increased risk of cardiovascular disease, so it would make sense that homocysteine-lowering supplements like folic acid could reduce one s risk of heart disease but a new study in the Archives of Internal Medicine failed to find evidence supporting such an effect.

High levels of the amino acid homocysteine have been associated with an increased risk of cardiovascular disease, so it would make sense that homocysteine-lowering supplements like folic acid could reduce one s risk of heart disease but a new study in the Archives of Internal Medicine failed to find evidence supporting such an effect.

Healthy lifestyle decreases breast cancer risk despite family disease history

By ACSH Staff — Oct 13, 2010
According to a new study in the journal Breast Cancer Research, your genes may not be to blame for everything. Researchers found that independent of a woman’s family history of invasive breast cancer, she can still lower her risk of developing the disease by about one-fourth through healthy lifestyle choices.

According to a new study in the journal Breast Cancer Research, your genes may not be to blame for everything. Researchers found that independent of a woman’s family history of invasive breast cancer, she can still lower her risk of developing the disease by about one-fourth through healthy lifestyle choices.

Additional screening tests not necessary for advanced cancers

By ACSH Staff — Oct 13, 2010
Patients diagnosed with cancer who only have a few remaining years of life left still often undergo routine mammograms, PSA tests and colonoscopies tests that are needless and wasteful because they re highly unlikely to benefit the patients screened, researchers of a new study in the Journal of the American Medical Association say.

Patients diagnosed with cancer who only have a few remaining years of life left still often undergo routine mammograms, PSA tests and colonoscopies tests that are needless and wasteful because they re highly unlikely to benefit the patients screened, researchers of a new study in the Journal of the American Medical Association say.